Clinical Trials Directory

Trials / Unknown

UnknownNCT02453126

Fibrostenotic Eosinophilic Esophagitis: Assessment Tools

Fibrostenotic Eosinophilic Esophagitis: Endoscopic, Histologic and Molecular Characterization and Evaluation of Clinical Assessment Tools

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This protocol addresses a central hypothesis that fibrostenotic Eosinophilic Esophagitis (EoE) is characterized by abnormal esophageal structure and compliance compared to non fibrostenotic EoE and that distinctive cellular and molecular profiles predict the fibrostenotic phenotype. This study aims to define and assess the changes that occur in the structure and dynamics of the esophageal wall in pediatric Eosinophilic Esophagitis along with characterizing the histologic and molecular patterns in fibrostenotic EoE.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2015-05-25
Last updated
2024-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02453126. Inclusion in this directory is not an endorsement.

Fibrostenotic Eosinophilic Esophagitis: Assessment Tools (NCT02453126) · Clinical Trials Directory